One of the biggest worldwide metabolic shifts of the 21st century is childhood obesity. Since 1975, the prevalence of childhood and teenage obesity has increased more than 10-fold, according to pooled research from 200 countries.^1,2 Over 340 million people between the ages of 5 and 19 are estimated to be overweight or obese worldwide, with the sharpest increases seen in low- and middle-income countries (LMICs) that are rapidly changing their food and economic systems.^2,3

According to an examination of specific trends in the number of overweight or obese children, prevalence has risen during the previous two to three decades in most industrialised nations, except Poland and Russia, as well as several low-income nations, particularly in metropolitan areas. In Australia, Brazil, Canada, Chile, Finland, France, Germany, Greece, Japan, the UK, and the USA, prevalence either quadrupled or tripled between the early 1970s and the late 1990s. By 2010, it was estimated that over 40% of children in the WHO regions of North America and the eastern Mediterranean, 38% in Europe, 27% in the western Pacific, and 22% in Southeast Asia would be overweight or obese. The 2006 review, however, predates more recent statistics, which indicate that the rise in childhood obesity in the USA, the UK, and Sweden may be slowing, but it is still too early to say for sure.

Notably, the conventional urban-centric paradigm is being challenged by rural body mass index increases, which now significantly contribute to the global obesity burden.³ Stunting and obesity coexist within the same populations and households in LMICs, posing a dual burden.⁴ This convergence indicates structural changes in labor practices, environmental exposures, and food systems.

Longitudinal research mainly challenges the prevalent appreciation of childhood obesity as a reversible behavioral problem. Obese children are five times more likely to become obese adults, and BMI is tightly correlated from childhood into adulthood.⁵ More importantly, regardless of adult BMI, early obesity predicts type 2 diabetes, cardiovascular disease, and early mortality.^6,7

Childhood obesity causes long-lasting physiological changes, such as endothelial dysfunction, arterial stiffness, insulin resistance, adipocyte hyperplasia, and chronic inflammation, according to mechanistic evidence.^6,8 Once increased during embryonic periods, the number of adipocytes shows little reversibility, indicating structural metabolic embedding.⁸

Risk is also increased by the metabolic state of the mother. Excessive prenatal weight gain and elevated pre-pregnancy BMI greatly raise the risk of childhood obesity in offspring.⁹ Early susceptibility is established by fetal metabolic programming processes, such as altered insulin signaling and epigenetic alteration.^7,10

Research from the Developmental Origins of Health and Disease (DOHaD) shows that cardiometabolic vulnerability is passed down through generations due to maternal obesity.^10,11,12 Higher obesity trajectories, early insulin resistance, and a higher lifetime cardiometabolic risk are all present in children born to women with metabolic dysregulation.^9,10

An amplification loop is created as a result: Obesity in mothers leads to fetal metabolic programming, childhood obesity, adult cardiometabolic disease, and next-generation maternal metabolic risk. In LMICs with little socioeconomic development, this kind of intergenerational cycling speeds up the epidemiologic transition.⁴

Despite decades of lifestyle changes, the increased incidence persists, indicating significant structural factors. Global dietary exposure has changed due to the spread of ultra-processed foods, intensive commercial promotion, and fiscal policies that favour goods high in calories.¹³ Reduced physical activity and digital sedentarism both contribute to a favourable energy balance.¹⁴

Adipogenesis and metabolic signaling may be further impacted by exposure to hormone-disrupting substances.¹⁵ A higher risk of overweight during infancy is also linked to early formula exposure and a changed newborn gut microbiome.¹⁶

According to systematic evaluations, the majority of lifestyle treatments have limited scalability in underprivileged communities and very small, short-term impacts.^14,17 These results highlight how ineffective linear prevention approaches are in feedback-stabilized obesogenic systems.

Over the next 20 years, increased pediatric obesity will significantly raise the incidence of early-onset type 2 diabetes and cardiovascular disease, according to modelling estimates.^1,6 In emerging economies with limited health systems, childhood obesity is likely to emerge as the primary upstream factor of 21st-century cardiometabolic multimorbidity in the absence of systemic intervention.

Reframing juvenile obesity as a metabolic lock-in phenomenon at the systems level explains why present strategies have reached a standstill and identifies structural leverage areas for prevention.

In order to measure embryonic metabolic lock-in and predict the intergenerational amplification of childhood obesity as a driver of cardio-metabolic multimorbidity until 2040, this study used integrative modelling at the systems level.

To predict obesity trajectories and the subsequent cardiometabolic implications, we combined data from various sources:

There were no primary human subjects used. Only de-identified, publicly accessible data sources were used in the analyses.

We developed a multidomain life-course model integrating four interacting systems:

A directed acyclic systems diagram defined causal pathways, feedback structures, and lagged effects before simulation (Figure 1). The model structure follows standard causal-loop systems terminology, distinguishing reinforcing (R) feedback loops governing intergenerational amplification and balancing (B) loops representing intervention and mortality effects.^18,19 This nomenclature is applied consistently in all diagrams and supplementary system maps.

Policy elasticities were derived from meta-analyses, quasi-experimental studies, and natural policy experiments (e.g., sugar taxation, food reformulation policies). Elasticities represent the proportional change in BMI transition probabilities per unit change in exposure.

For each policy:ΔP=ε×ΔE Where:

ΔP = change in transition probability

ε = elasticity coefficient

ΔE = exposure shift

Regional heterogeneity was incorporated by sampling ε from distributional ranges specific to income group and urbanization level (Table 1).

Sensitivity analyses (±30%) were conducted to assess the robustness of projections to elasticity uncertainty. Scenario outputs were verified to be internally consistent with elasticity assumptions.

All elasticity values and sources are reported in Tables 1 and S7.

All figures, tables, and numerical outputs are generated through fully automated scripts. A single-command execution pipeline reproduces the complete analysis from raw parameter inputs, ensuring computational reproducibility and eliminating manual post-processing.

The prevalence of pediatric obesity continues to climb globally, according to simulations under the status quo scenario.^24,38,39

Global prevalence rises from 12.3% in 2025 to 15.8% in 2040 (Table 4).^38,39

Regional trends:

Due to growing urbanization, shifts in nutrition, and sedentary lifestyles, upper-middle-income nations see the largest absolute increase (~5.2 points).^24,38

Low-income nations exhibit slower growth (~1.8 points), which is consistent with increased exposure to ultra-processed foods but less availability of calories.³⁹

Urban lifestyle effects are highlighted by the consistently higher predicted frequency in urban populations when compared to rural populations (Table 4).^23,38,39,40

Projected global and income-stratified childhood obesity prevalence (%) from 2025 to 2040 under status quo conditions. Lines represent mean projections from 10,000 Monte Carlo simulations. Shaded bands indicate 95% uncertainty intervals (UI). Projections incorporate age-, sex-, and region-specific BMI (kg/m²) transition probabilities and demographic forecasts. All uncertainty intervals reflect probabilistic variation in transition matrices, hazard ratios, and intergenerational parameter γ.

We calculated the incidence cardiometabolic burden associated with early-life obesity using age- and sex-specific risk ratios.^25,41,42

It is anticipated that the number of cases of early-onset type 2 diabetes (less than 40 years old) will grow by 46% from 5.8 million in 2025 to 8.5 million in 2040 (Table 5).²⁵

The number of cases of premature cardiovascular disease (less than 60 years old) is expected to rise from 3.7 to 5.2 million, with the majority occurring in high- and upper-middle-income nations.⁴¹

Childhood obesity-related mortality increases from 1.1 million in 2025 to 1.6 million in 2040 due to both direct and indirect cardiometabolic consequences (Table 5 and Figure 4).⁴²

Economic evaluation framework

Economic burden was estimated using a cost-of-illness approach incorporating direct healthcare costs and health-adjusted life years.

DALYs were calculated as:DALY=YLL+YLD Where:

YLL = deaths × standard life expectancy

YLD = incidence × disability weight

QALYs were derived using health-state utility weights.

Per-case cost estimates were obtained from WHO-CHOICE and national cost-of-illness datasets, stratified by region and income group. All costs were converted to constant 2023 international dollars using purchasing power parity (PPP) conversion factors (World Bank).

Discounting:

Regional breakdowns of DALYs, QALYs, and costs are reported in Table S7, with aggregated global estimates presented in the main text.

Probabilistic uncertainty in costs and outcomes was propagated using Monte Carlo simulation (10,000 iterations).

Regional economic burden

Upper-middle-income regions accounted for the largest share of projected economic burden due to higher disease incidence and healthcare costs, whereas low-income regions exhibited lower absolute costs but higher relative disease burden per healthcare capacity.

Projected early-onset type 2 diabetes (<40 years), premature cardiovascular disease (<60 years), and population-attributable mortality associated with childhood obesity. Bars represent mean projected cases (millions), with error bars denoting 95% uncertainty intervals (UI) from 10,000 Monte Carlo simulations. Disease incidence was estimated using BMI-category–specific HR (95% CI) applied to baseline incidence functions with log-normal uncertainty propagation.

Absolute disease burden projections under each scenario are detailed in Table S4.

Obesity prevalence is increased throughout generations by maternal–offspring transmission^18,26,27,28 (Figure 5).

Table S1 describes the sensitivity testing of γ (±25%) and its probabilistic distribution.

Maternal obesity adds +2.1% absolute increase in the prevalence of childhood obesity by 2040 if nothing is done (status quo).²⁶

Simulations of policies show significant mitigation:

Prevalence is reduced by 1.8 points (14.0% overall) by fiscal nutrition reform.¹⁸

Prevalence is decreased by 2.5 points (13.3% overall) with maternal metabolic optimization.^27,28

Intergenerational amplification is successfully countered by combined therapies, which lower prevalence by 4.1 points (11.7% overall)^18,26,27,28 (Table 6).

Table S2 shows regional differences in policy effects.

Projected childhood obesity prevalence (%) under four modeled scenarios: Status quo, Fiscal nutrition reform, Maternal metabolic optimization, and Combined intervention. Lines represent mean projections; shaded regions represent 95% uncertainty intervals (UI). Policy exposure shifts were translated into BMI transition probability modifications using elasticity-based parameterization (Supplementary Section S3.1). Combined interventions demonstrate the greatest mitigation of intergenerational amplification via γ.

All projections presented in figures represent mean estimates derived from 10,000 Monte Carlo simulations. Uncertainty is expressed as 95% uncertainty intervals (UI). BMI values are reported as kg/m², hazard ratios as HR (95% CI), DALYs as total and per 100,000 population where applicable, and the intergenerational transmission parameter is denoted γ.

Supplementary Analyses Overview (Aligned with Supplementary File S1–S7).

Global childhood obesity is projected to rise steadily, fastest in upper-middle-income countries.^24,38,39

Cardiometabolic disease burden attributable to childhood obesity will grow, emphasizing early-life interventions.^25,41,42

Maternal–offspring feedback loops amplify prevalence, but combined policy interventions can substantially mitigate future risk.^18,26,27,28

Monte Carlo and sensitivity analyses confirm robustness, with regional heterogeneity identifying priority intervention targets.^{18,24,25,26,27,38,39,41,42}

Under the combined intervention scenario, the model projects an absolute reduction of 4.1 percentage points in global childhood obesity prevalence by 2040 (15.8% to 11.7%). This corresponds to 2.9 million fewer early-onset type 2 diabetes cases, 1.9 million fewer premature cardiovascular disease cases, and 0.7 million fewer attributable deaths compared with status quo projections.

These reductions translate to approximately 18.1 million QALYs gained, 18.1 million DALYs averted relative to fiscal reform alone, and an estimated USD 190 billion in net healthcare savings by 2040 (Table S7).

According to the analysis, childhood obesity will continue to rise in the absence of early-life and intergenerational treatments, leading to an increase in cardiometabolic disease and early mortality worldwide.

Among the suggested policies are:

Implement integrated nutrition programs for mothers and children that focus on preconception and the early years of childhood.

Implement population-level policies to limit exposure to ultra-processed foods, especially in middle-income urbanized nations.

Give priority to multigenerational health initiatives, such as community involvement, family-level behavioral interventions, and school-based nutrition instruction.

To improve model precision and fine-tune region-specific parameters, spend money on data gathering and surveillance.

Up to a 4.1% absolute decrease in the prevalence of childhood obesity worldwide by 2040 is predicted if these tactics are used in concert, significantly reducing the burden of disease in the future and enhancing public health.^11,12,40

Scenario-specific exposure reductions and modeling assumptions are detailed in the Supplementary Methods, with full numerical outputs presented in Tables S2–S4.

Projections indicate disproportionate acceleration of the obesity burden in lower-middle-income and rapidly urbanizing regions. Structural food environment transitions, digital sedentary behaviors, circadian disruption, endocrine-disrupting chemical exposure, and emerging pharmacologic interventions (e.g., GLP-1 receptor agonists in adolescents) represent evolving determinants not fully captured in current projections.^38,39,41,42

Sensitivity analyses demonstrate that model outcomes are moderately responsive to elasticity assumptions but remain directionally stable across plausible parameter ranges. Economic projections are most sensitive to discount rates and per-case cost estimates, reinforcing the importance of early-life interventions with long-term benefit horizons.^{24,25,26,27,28}